Literature DB >> 10452554

Peptide models for inherited neurodegenerative disorders: conformation and aggregation properties of long polyglutamine peptides with and without interruptions.

D Sharma1, S Sharma, S Pasha, S K Brahmachari.   

Abstract

Several neurodegenerative diseases are caused by expansion of polyglutamine repeats in the affected proteins. In spino-cerebellar ataxia type 1 (SCA1), histidine interruptions have been reported to mitigate the pathological effects of long glutamine stretches. To understand this phenomenon, we investigated the conformational preferences of peptides containing both the uninterrupted polyglutamine stretches and those with histidine interruption(s) as seen in SCA1 normals. Our study suggests that substitution of histidines by glutamines induces a conformational change which results in decreased solubility and increased aggregation. Our findings also suggest that all the polyglutamine peptides with and without interruption(s) adopt a beta-structure and not random coil.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10452554     DOI: 10.1016/s0014-5793(99)00933-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  28 in total

1.  Solubilization and disaggregation of polyglutamine peptides.

Authors:  S Chen; R Wetzel
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

2.  A structural model of polyglutamine determined from a host-guest method combining experiments and landscape theory.

Authors:  John M Finke; Margaret S Cheung; José N Onuchic
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

Review 3.  Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence.

Authors:  Ronald Wetzel
Journal:  J Mol Biol       Date:  2012-01-27       Impact factor: 5.469

Review 4.  Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications.

Authors:  Qian Huang; Maria E Figueiredo-Pereira
Journal:  Apoptosis       Date:  2010-11       Impact factor: 4.677

5.  Modulation of polyglutamine conformations and dimer formation by the N-terminus of huntingtin.

Authors:  Tim E Williamson; Andreas Vitalis; Scott L Crick; Rohit V Pappu
Journal:  J Mol Biol       Date:  2009-12-21       Impact factor: 5.469

6.  Variability in a Short Tandem Repeat Mediates Complex Epistatic Interactions in Arabidopsis thaliana.

Authors:  Maximilian Oliver Press; Christine Queitsch
Journal:  Genetics       Date:  2016-11-18       Impact factor: 4.562

7.  UV resonance Raman spectroscopy monitors polyglutamine backbone and side chain hydrogen bonding and fibrillization.

Authors:  Kan Xiong; David Punihaole; Sanford A Asher
Journal:  Biochemistry       Date:  2012-07-12       Impact factor: 3.162

8.  Tissue transglutaminase crosslinks ataxin-1: possible role in SCA1 pathogenesis.

Authors:  D R D'Souza; J Wei; Q Shao; M D Hebert; S H Subramony; P J S Vig
Journal:  Neurosci Lett       Date:  2006-10-11       Impact factor: 3.046

Review 9.  A novel therapeutic strategy for polyglutamine diseases by stabilizing aggregation-prone proteins with small molecules.

Authors:  Motomasa Tanaka; Yoko Machida; Nobuyuki Nukina
Journal:  J Mol Med (Berl)       Date:  2005-03-10       Impact factor: 4.599

10.  Study of the aggregation mechanism of polyglutamine peptides using replica exchange molecular dynamics simulations.

Authors:  Miki Nakano; Kuniyoshi Ebina; Shigenori Tanaka
Journal:  J Mol Model       Date:  2013-01-05       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.